Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas-Reference-Cited by-同舟云学术

Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas

Published:2011-04-15 Issue:5 Volume:153 Page:599-611
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Brem Elizabeth A.,Thudium Karen,Khubchandani Sapna,Tsai Ping-Chiao,Olejniczak Scott H.,Bhat Seema,Riaz Wasif,Gu Jenny,Iqbal Arshad,Campagna Ryan,Knight Joy,Mavis Cory,Hoskin Paul,Deeb George,Gibbs John F.,Fetterly Gerald,Czuczman Myron S.,Hernandez-Ilizaliturri Francisco J.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08669.x/fullpdf

Reference52 articles.

1. Subversion of the Bcl-2 life/death switch in cancer development and therapy;Adams;Cold Spring Harbor Symposia on Quantitative Biology,2005

2. A molecular basis for drug action;Ariuens;Journal of Pharmacy and Pharmacology,1964

3. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance;Bannerji;Journal of Clinical Oncology,2003

4. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group;Bedikian;Journal of Clinical Oncology,2006

5. Pharmacodynamic interaction of recombinant human interleukin-10 and prednisolone using in vitro whole blood lymphocyte proliferation;Chakraborty;Journal of Pharmaceutical Sciences,2002

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy;Cells;2023-07-25

2. Therapeutics targeting BCL2 family proteins;Mechanisms of Cell Death and Opportunities for Therapeutic Development;2022

3. Computational study on novel natural inhibitors targeting BCL2;Medical Oncology;2021-07-14

4. Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma;Cancers;2021-04-30

5. Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab;Journal of Controlled Release;2020-12